Skip to main content
Top
Published in: BMC Infectious Diseases 1/2017

Open Access 01-12-2017 | Research article

Thromboelastometry analysis of thrombocytopenic dengue patients: a cross-sectional study

Authors: Felipe Maia de Toledo Piza, Thiago Domingos Corrêa, Alexandre Rodrigues Marra, João Carlos Campos Guerra, Roseny dos Reis Rodrigues, Andrea Aparecida Rocco Villarinho, Valdir Fernandes de Aranda, Sandra Christina Pereira Lima Shiramizo, Maria Roza de Jesus de Lima, Esper Georges Kallas, Alexandre Biasi Cavalcanti

Published in: BMC Infectious Diseases | Issue 1/2017

Login to get access

Abstract

Background

Dengue virus infection (DVI) is a prevalent and potentially fatal viral disease associated with coagulopathy. So far, the coagulation profile of DVI patients with thrombocytopenia has not been assessed through a viscoelastic test such as rotational thromboelastometry. We aimed to describe the prevalence and characteristics of coagulation abnormalities in dengue fever outpatients with thrombocytopenia, addressed by both rotational thromboelastometry and conventional coagulation tests.

Methods

This was a cross-sectional study conducted between April 6th and May 5th 2015 in São Paulo, Brazil during a dengue outbreak. Thromboelastometry (ROTEM®) and the conventional coagulation tests prothrombin time (PT), international normalized ratio (INR), activated partial thromboplastin time (aPTT), thrombin time (TT), platelet count and fibrinogen levels were performed in 53 patients with DVI and thrombocytopenia.

Results

Despite a median interquartile range (IQR) platelet count of 77 (63–88) x 109/L in DVI patients, conventional coagulation tests and plasma fibrinogen levels were within the normal range. Subjects demonstrated hypocoagulability in 71.7% (38/53) in INTEM and 54.7% (29/53) in EXTEM DVI patients. FIBTEM analyses detected only 5.7% (3/53) with hypocoagulability among this population. The median (IQR) clotting time (CT), clot formation time (CFT) and maximum clot firmness (MCF) on INTEM were, respectively, 177 (160–207) sec, 144 (108–178) sec and 48 (42–52) mm. On EXTEM, median (IQR) CT, CFT and MCF were, respectively, 69 (65–78) sec, 148 (126–198) sec and 49 (44–55) mm. Median (IQR) MCF on FIBTEM was 15 (13–18) mm.

Conclusion

Thromboelastometry impairment is highly prevalent in DVI patients with thrombocytopenia, particularly in INTEM and EXTEM analyses, while standard coagulation tests are normal in this setting. Clinical implications remain to be established.
Literature
3.
go back to reference Kurane I. Dengue hemorrhagic fever with special emphasis on immunopathogenesis. Comp Immunol Microb. 2007;30(5–6):329–40.CrossRef Kurane I. Dengue hemorrhagic fever with special emphasis on immunopathogenesis. Comp Immunol Microb. 2007;30(5–6):329–40.CrossRef
4.
go back to reference Srikiatkhachorn A. Plasma leakage in dengue haemorrhagic fever. Thromb Haemost. 2009;102(6):1042–9.PubMed Srikiatkhachorn A. Plasma leakage in dengue haemorrhagic fever. Thromb Haemost. 2009;102(6):1042–9.PubMed
5.
go back to reference Guzman M. Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. J Clin Virol. 2003;27(1):1–13.CrossRefPubMed Guzman M. Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. J Clin Virol. 2003;27(1):1–13.CrossRefPubMed
6.
go back to reference Chuang YC, Lin YS, Liu CC, Liu HS, Liao SH, Shi MD, et al. Factors contributing to the disturbance of coagulation and fibrinolysis in dengue virus infection. J Formos Med Assoc. 2013;112(1):12–7.CrossRefPubMed Chuang YC, Lin YS, Liu CC, Liu HS, Liao SH, Shi MD, et al. Factors contributing to the disturbance of coagulation and fibrinolysis in dengue virus infection. J Formos Med Assoc. 2013;112(1):12–7.CrossRefPubMed
7.
go back to reference Hottz ED, Oliveira MF, Nunes PC, Nogueira RM, Valls-de-Souza R, Da Poian AT, et al. Dengue induces platelet activation, mitochondrial dysfunction and cell death through mechanisms that involve DC-SIGN and caspases. J Thromb Haemost. 2013;11(5):951–62.CrossRefPubMedPubMedCentral Hottz ED, Oliveira MF, Nunes PC, Nogueira RM, Valls-de-Souza R, Da Poian AT, et al. Dengue induces platelet activation, mitochondrial dysfunction and cell death through mechanisms that involve DC-SIGN and caspases. J Thromb Haemost. 2013;11(5):951–62.CrossRefPubMedPubMedCentral
8.
go back to reference Chua MN, Molanida R, de Guzman M, Laberiza F. Prothrombin time and partial thromboplastin time as a predictor of bleeding in patients with dengue hemorrhagic fever. Se Asian J Trop Med. 1993;24 Suppl 1:141–3. Chua MN, Molanida R, de Guzman M, Laberiza F. Prothrombin time and partial thromboplastin time as a predictor of bleeding in patients with dengue hemorrhagic fever. Se Asian J Trop Med. 1993;24 Suppl 1:141–3.
9.
go back to reference Wills BA, Oragui EE, Stephens AC, Daramola OA, Dung NM, Loan HT, et al. Coagulation abnormalities in dengue hemorrhagic Fever: serial investigations in 167 Vietnamese children with dengue shock syndrome. Clin Infect Dis. 2002;35:277–85.CrossRefPubMed Wills BA, Oragui EE, Stephens AC, Daramola OA, Dung NM, Loan HT, et al. Coagulation abnormalities in dengue hemorrhagic Fever: serial investigations in 167 Vietnamese children with dengue shock syndrome. Clin Infect Dis. 2002;35:277–85.CrossRefPubMed
11.
go back to reference Favaloro EJ, Lippi G. Coagulation update: What’s new in hemostasis testing? Thromb Res. 2011;127:S13–6.CrossRefPubMed Favaloro EJ, Lippi G. Coagulation update: What’s new in hemostasis testing? Thromb Res. 2011;127:S13–6.CrossRefPubMed
12.
go back to reference Mallett SV, Armstrong M. Point-of-care monitoring of haemostasis. Anaesthesia. 2015;70 Suppl 1:73–7. e25-6.CrossRefPubMed Mallett SV, Armstrong M. Point-of-care monitoring of haemostasis. Anaesthesia. 2015;70 Suppl 1:73–7. e25-6.CrossRefPubMed
13.
go back to reference McMichael MA, Smith SA. Viscoelastic coagulation testing: technology, applications, and limitations. Vet Clin Path. 2011;40(2):140–53.CrossRef McMichael MA, Smith SA. Viscoelastic coagulation testing: technology, applications, and limitations. Vet Clin Path. 2011;40(2):140–53.CrossRef
14.
go back to reference Reikvam H, Steien E, Hauge B, Liseth K, Hagen KG, Storkson R, et al. Thrombelastography. Transfus Apher Sci. 2009;40(2):119–23.CrossRefPubMed Reikvam H, Steien E, Hauge B, Liseth K, Hagen KG, Storkson R, et al. Thrombelastography. Transfus Apher Sci. 2009;40(2):119–23.CrossRefPubMed
15.
go back to reference Whiting D, DiNardo JA. TEG and ROTEM: technology and clinical applications. Am J Hematol. 2014;89(2):228–32.CrossRefPubMed Whiting D, DiNardo JA. TEG and ROTEM: technology and clinical applications. Am J Hematol. 2014;89(2):228–32.CrossRefPubMed
16.
go back to reference Stensballe J, Ostrowski SR, Johansson PI. Viscoelastic guidance of resuscitation. Curr Opin Anesthesio. 2014;27(2):212–8.CrossRef Stensballe J, Ostrowski SR, Johansson PI. Viscoelastic guidance of resuscitation. Curr Opin Anesthesio. 2014;27(2):212–8.CrossRef
17.
go back to reference Díaz-Quijano FA. Predictors of spontaneous bleeding in dengue patients: a systematic review of the literature. Invest Clin. 2008;49:111–22.PubMed Díaz-Quijano FA. Predictors of spontaneous bleeding in dengue patients: a systematic review of the literature. Invest Clin. 2008;49:111–22.PubMed
18.
go back to reference Diaz-Quijano FA, Villar-Centeno LA, Martinez-Vega RA. Predictors of spontaneous bleeding in patients with acute febrile syndrome from a dengue endemic area. J Clin Virol. 2010;49:11–5.CrossRefPubMed Diaz-Quijano FA, Villar-Centeno LA, Martinez-Vega RA. Predictors of spontaneous bleeding in patients with acute febrile syndrome from a dengue endemic area. J Clin Virol. 2010;49:11–5.CrossRefPubMed
19.
go back to reference de Azeredo EL, Monteiro RQ, de-Oliveira Pinto LM. Thrombocytopenia in dengue: interrelationship between virus and the imbalance between coagulation and fibrinolysis and inflammatory mediators. Mediat Inflamm. 2015, Article ID 313842, 16 pages. de Azeredo EL, Monteiro RQ, de-Oliveira Pinto LM. Thrombocytopenia in dengue: interrelationship between virus and the imbalance between coagulation and fibrinolysis and inflammatory mediators. Mediat Inflamm. 2015, Article ID 313842, 16 pages.
20.
go back to reference Orsi FA, Angerami RN, Mazetto BM, Quaino SK, Santiago-Bassora F, Castro V, et al. Reduced thrombin formation and excessive fibrinolysis are associated with bleeding complications in patients with dengue fever: a case–control study comparing dengue fever patients with and without bleeding manifestations. BMC Infect Dis. 2013, 3(1), article 350. Orsi FA, Angerami RN, Mazetto BM, Quaino SK, Santiago-Bassora F, Castro V, et al. Reduced thrombin formation and excessive fibrinolysis are associated with bleeding complications in patients with dengue fever: a case–control study comparing dengue fever patients with and without bleeding manifestations. BMC Infect Dis. 2013, 3(1), article 350.
21.
go back to reference Nimmannitya S. Dengue hemorrahagic fever: disorders of hemostasia. Bangkok, Thailand: Proceeding International Congress of Hemotology, Asia-Pacific Division; 1999. Nimmannitya S. Dengue hemorrahagic fever: disorders of hemostasia. Bangkok, Thailand: Proceeding International Congress of Hemotology, Asia-Pacific Division; 1999.
22.
23.
go back to reference Fries D, Martini WZ. Role of fibrinogen in trauma-induced coagulopathy. Brit J Anaesth. 2010;105(2):116–21.CrossRefPubMed Fries D, Martini WZ. Role of fibrinogen in trauma-induced coagulopathy. Brit J Anaesth. 2010;105(2):116–21.CrossRefPubMed
24.
go back to reference Taylor FB, Toh CH, Hoots WK, Wada H. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86:1327–30.PubMed Taylor FB, Toh CH, Hoots WK, Wada H. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86:1327–30.PubMed
25.
go back to reference Funahara Y, Sumarmo, Wirawan R. Features of DIC in dengue hemorrhagic fever. Bibl Haematol. 1983;49:201–11. Funahara Y, Sumarmo, Wirawan R. Features of DIC in dengue hemorrhagic fever. Bibl Haematol. 1983;49:201–11.
26.
go back to reference Ganter MT, Hofer CK. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg. 2008;106(5):1366–75.CrossRefPubMed Ganter MT, Hofer CK. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg. 2008;106(5):1366–75.CrossRefPubMed
27.
go back to reference Schochl H, Nienaber U, Hofer G, Voelckel W, Jambor C, Scharbert G, et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care. 2010;14(2):R55.CrossRefPubMedPubMedCentral Schochl H, Nienaber U, Hofer G, Voelckel W, Jambor C, Scharbert G, et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care. 2010;14(2):R55.CrossRefPubMedPubMedCentral
28.
go back to reference Sniecinski RM, Levy JH. Bleeding and management of coagulopathy. J Thorac Cardiovasc Surg. 2011;142(3):662–7.CrossRefPubMed Sniecinski RM, Levy JH. Bleeding and management of coagulopathy. J Thorac Cardiovasc Surg. 2011;142(3):662–7.CrossRefPubMed
29.
go back to reference Perry DJ, Fitzmaurice DA, Kitchen S, Mackie IJ, Mallett S. Point-of-care testing in haemostasis. Brit J Haematol. 2010;150(5):501–14.CrossRef Perry DJ, Fitzmaurice DA, Kitchen S, Mackie IJ, Mallett S. Point-of-care testing in haemostasis. Brit J Haematol. 2010;150(5):501–14.CrossRef
30.
go back to reference Rigau-Pérez JG, Clark GG, Gubler DJ, Reiter P, Sanders EJ, Vorndam AV. Dengue and dengue haemorrhagic fever. Lancet. 1998;352(9132):971–7.CrossRefPubMed Rigau-Pérez JG, Clark GG, Gubler DJ, Reiter P, Sanders EJ, Vorndam AV. Dengue and dengue haemorrhagic fever. Lancet. 1998;352(9132):971–7.CrossRefPubMed
31.
go back to reference Singhi S, Kissoon N, Bansal A. Dengue and dengue hemorrhagic fever: management issues in an intensive care unit. J Pediatr. 2007;83(2 Suppl):S22–35.CrossRef Singhi S, Kissoon N, Bansal A. Dengue and dengue hemorrhagic fever: management issues in an intensive care unit. J Pediatr. 2007;83(2 Suppl):S22–35.CrossRef
32.
go back to reference Pea L, Roda L, Moll F. Desmopressin treatment for a case of dengue hemorrhagic fever/dengue shock syndrome. Clin Infect Dis. 2001;33(9):1611–2.CrossRefPubMed Pea L, Roda L, Moll F. Desmopressin treatment for a case of dengue hemorrhagic fever/dengue shock syndrome. Clin Infect Dis. 2001;33(9):1611–2.CrossRefPubMed
33.
go back to reference Neff AT, Sidonio Jr RF. Management of VWD. Hematology Am Soc Hematol Educ Program. 2014;2014(1):536–41.PubMed Neff AT, Sidonio Jr RF. Management of VWD. Hematology Am Soc Hematol Educ Program. 2014;2014(1):536–41.PubMed
35.
go back to reference Ho TS, Wang SM, Lin YS, Liu CC. Clinical and laboratory predictive markers for acute dengue infection. J Biomed Sci. 2013, 20(1), article 75. Ho TS, Wang SM, Lin YS, Liu CC. Clinical and laboratory predictive markers for acute dengue infection. J Biomed Sci. 2013, 20(1), article 75.
36.
go back to reference Kozek-Langenecker SA. Fluids and coagulation. Curr Opin Criti Care. 2015;21(4):285–91.CrossRef Kozek-Langenecker SA. Fluids and coagulation. Curr Opin Criti Care. 2015;21(4):285–91.CrossRef
38.
go back to reference Karon BS. Why is everyone so excited about thromboelastrography (TEG)? Clin Chim Acta. 2014;436:143–8.CrossRefPubMed Karon BS. Why is everyone so excited about thromboelastrography (TEG)? Clin Chim Acta. 2014;436:143–8.CrossRefPubMed
39.
go back to reference Levy JH, Dutton RP, Hemphill 3rd JC, Shander A, Cooper D, Paidas MJ, et al. Multidisciplinary approach to the challenge of hemostasis. Anesth Analg. 2010;110(2):354–64.CrossRefPubMed Levy JH, Dutton RP, Hemphill 3rd JC, Shander A, Cooper D, Paidas MJ, et al. Multidisciplinary approach to the challenge of hemostasis. Anesth Analg. 2010;110(2):354–64.CrossRefPubMed
40.
go back to reference Vickers IE, Harvey KM, Brown MG, Nelson K, DuCasse MB, Lindo JF. The performance of the SD BIOLINE Dengue DUO® rapid immunochromatographic test kit for the detection of NS1 antigen, IgM and IgG antibodies during a dengue type 1 epidemic in Jamaica. J Biomed Sci. 2015;22:55.CrossRefPubMedPubMedCentral Vickers IE, Harvey KM, Brown MG, Nelson K, DuCasse MB, Lindo JF. The performance of the SD BIOLINE Dengue DUO® rapid immunochromatographic test kit for the detection of NS1 antigen, IgM and IgG antibodies during a dengue type 1 epidemic in Jamaica. J Biomed Sci. 2015;22:55.CrossRefPubMedPubMedCentral
41.
go back to reference Zammarchi L, Tappe D, Fortuna C, Remoli ME, Günter S, Venturi G, et al. Zika virus infection in a traveler returning to Europe from Brazil, March 2015. Euro Surveill. 2015;20:(23).CrossRef Zammarchi L, Tappe D, Fortuna C, Remoli ME, Günter S, Venturi G, et al. Zika virus infection in a traveler returning to Europe from Brazil, March 2015. Euro Surveill. 2015;20:(23).CrossRef
Metadata
Title
Thromboelastometry analysis of thrombocytopenic dengue patients: a cross-sectional study
Authors
Felipe Maia de Toledo Piza
Thiago Domingos Corrêa
Alexandre Rodrigues Marra
João Carlos Campos Guerra
Roseny dos Reis Rodrigues
Andrea Aparecida Rocco Villarinho
Valdir Fernandes de Aranda
Sandra Christina Pereira Lima Shiramizo
Maria Roza de Jesus de Lima
Esper Georges Kallas
Alexandre Biasi Cavalcanti
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2017
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-017-2204-4

Other articles of this Issue 1/2017

BMC Infectious Diseases 1/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.